Hospital-based programs democratize mRNA therapeutics by facilitating the processes to translate a novel RNA idea from the bench to the clinic. Because mRNA is essentially biological software, therapeutic RNA constructs can be rapidly developed. The generation of small batches of clinical grade mRNA to support IND applications and first-in-man clinical trials, as well as personalized mRNA therapeutics delivered at the point-of-care, is feasible at a modest scale of cGMP manufacturing. Advances in mRNA manufacturing science and innovations in mRNA biology, are increasing the scope of mRNA clinical applications.
Original languageEnglish (US)
Title of host publicationmRNA Therapeutics
Subtitle of host publicationSpringer
StateAccepted/In press - Dec 14 2021


Dive into the research topics of 'Hospital-Based RNA Therapeutics'. Together they form a unique fingerprint.

Cite this